When was Avalon Pharmaceuticals founded?
Avalon Pharmaceuticals was founded in 1999.
Where is Avalon Pharmaceuticals's headquarters?
Avalon Pharmaceuticals's headquarters is located at 20358 Seneca Meadows Parkway, Germantown.
What is Avalon Pharmaceuticals's latest funding round?
Avalon Pharmaceuticals's latest funding round is Acquired.
How much did Avalon Pharmaceuticals raise?
Avalon Pharmaceuticals raised a total of $122.02M.
Who are the investors of Avalon Pharmaceuticals?
Investors of Avalon Pharmaceuticals include Clinical Data, BVF Partners, Federated Mutual Insurance Company, Federated Investors, Federated Equity Funds - Federated Kaufmann Fund and 35 more.
Who are Avalon Pharmaceuticals's competitors?
Competitors of Avalon Pharmaceuticals include LifeSensors, Melinta Therapeutics, BrightPath Biotherapeutics, Cellzome, LifeGen Technologies and 11 more.
You May Also Like
Sekmed is a biotechnology company working in the drug discovery and gene hunting field. The company's fishing nets are the company's DC-based bioassays, and the company are looking for catch: drug candidates to create vaccines, improve transplant acceptance and treat autoimmunity.
TcLand Expression is a provider in the field of gene expression biomarkers in immunology
CODA Genomics aims to take a biology process that normally yields an entire array of unspecific products, and through computer optimization and a step-wise process, directs an assembly of the desired product that is thermodynamically efficient. The company's CODExpress Gene kit aims to allow researchers to express custom proteins in their lab with their own gene constructs and variants.
Proteintech Group is engaged in the design, development and marketing of antibody and antibody-chips in the bioresearch field.
The bacteriophage vaccination technology originated at Moredun Research Institute when Dr. John March and Dr. Jason Clark were working on production of cheap, stable, efficient vaccines for use in developing countries.
GNI's "gene network" technology is based on a combination of wet lab work and lots of computing power to figure out how the 30,000-plus protein-making genes in the human genome interact. Its primary product is a drug discovery engine to quickly identify genes for drug development, as well as figure out which genes are affected by a given drug.
Discover the right solution for your team
The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.